Viewing Study NCT06497556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT06497556
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-07-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None KRAS G12C Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Non-Small Cell Lung Cancer View
None KRAS G12 Lung Cancer View
None Advanced Lung Cancer View
None Metastatic lung cancer View
None Divarasib View
None KRAS G12C Inhibitor View
None KRAS G12C Positive View
None KRAS Mutation View
None KRAS G12C Mutation View
None Lung Cancer Mutation View